Predicting Length-of-Stay & Risk of Mortality for ICU Patients

Pangaea Data Awarded Top Tier Co-Sell Partnership Status by Microsoft

Pangaea Named ‘Digital Solution of the Year’ by UK Government’s Department for International Trade

Global Pharmaceutical Proves Pangaea’s AI

Go back

“Characterizing Patients Using Medical Knowledge & AI to Discover More Patients”

12:35PM - 12:55PM PST September 6th 2023, Real World Evidence Track, Santa Clara, CA, USA

Visit Us at Booth 301

Venue: Santa Clara Convention Center, CA, USA

Presentation: Characterizing Patients Using Medical Knowledge and AI to Discover More Undiagnosed, Misdiagnosed & Miscoded Patients

Track: Real World Evidence

Pangaea’s product platform combines medical knowledge and novel AI to characterize patients to help clinicians find more undiagnosed, misdiagnosed and miscoded patients across 4,000 hard-to-diagnose conditions. This is achieved by Pangaea’s product capabilities to automatically discover clinically valid signatures (which clinicians otherwise ascertain through manual review) in a scalable and privacy-preserving manner across healthcare providers and pharmaceutical companies globally.

Pangaea’s knowledge-driven approach is helping to realize the true promise of preventative health and precision medicine through enabling sustainable, mutually beneficial collaborations between the healthcare and pharmaceutical industries. Thus, improving patient outcomes while simultaneously saving costs and time, without needing to transact data.

Please let us know if you are available to meet by registering through the link below or emailing us at

Register to Meet Us


Dr. Vibhor Gupta
Director & Founder
Pangaea Data
Mr. Marcin Burda
Biomedical Scientist
Pangaea Data